• Je něco špatně v tomto záznamu ?

Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner

K. Holubova, L. Kleteckova, M. Skurlova, J. Ricny, A. Stuchlik, K. Vales,

. 2016 ; 233 (11) : 2077-2097. [pub] 20160323

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17014001

Grantová podpora
NT13403 MZ0 CEP - Centrální evidence projektů

Digitální knihovna NLK
Plný text - Článek
Zdroj

E-zdroje Online Plný text

NLK ProQuest Central od 1997-02-01 do Před 1 rokem
Medline Complete (EBSCOhost) od 1996-10-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 1997-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 1997-02-01 do Před 1 rokem
Psychology Database (ProQuest) od 1997-02-01 do Před 1 rokem

OBJECTIVE: The aim of our study was to test whether ketamine produces an antidepressant effect in animal model of olfactory bulbectomy and assess the role of mammalian target of rapamycin (mTOR) pathway in ketamine's antidepressant effect. METHODS: Bulbectomized (OBX) rats and sham controls were assigned to four subgroups according to the treatment they received (ketamine, saline, ketamine + rapamycin, and saline + rapamycin). The animals were subjected to open field (OF), elevated plus maze (EPM), passive avoidance (PA), Morris water maze (MWM), and Carousel maze (CM) tests. Blood samples were collected before and after drug administration for analysis of phosphorylated mTOR level. After behavioral testing, brains were removed for evaluation of brain-derived neurotrophic factor (BDNF) in prefrontal cortex (PFC) and hippocampus. RESULTS: Ketamine normalized hyperactivity of OBX animals in EPM and increased the time spent in open arms. Rapamycin pretreatment resulted in elimination of ketamine effect in EPM test. In CM test, ketamine + rapamycin administration led to cognitive impairment not observed in saline-, ketamine-, or saline + rapamycin-treated OBX rats. Prefrontal BDNF content was significantly decreased, and level of mTOR was significantly elevated in OBX groups. CONCLUSIONS: OBX animals significantly differed from sham controls in most of the tests used. Treatment had more profound effect on OBX phenotype than controls. Pretreatment with rapamycin eliminated the anxiolytic and antidepressant effects of ketamine in task-dependent manner. The results indicate that ketamine + rapamycin application resulted in impaired stress responses manifested by cognitive deficits in active place avoidance (CM) test. Intensity of stressor (mild vs. severe) used in the behavioral tests had opposite effect on controls and on OBX animals.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014001
003      
CZ-PrNML
005      
20181026092655.0
007      
ta
008      
170413s2016 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00213-016-4256-3 $2 doi
035    __
$a (PubMed)27004790
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Holubová, Kristína $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic. $7 xx0278720
245    10
$a Rapamycin blocks the antidepressant effect of ketamine in task-dependent manner / $c K. Holubova, L. Kleteckova, M. Skurlova, J. Ricny, A. Stuchlik, K. Vales,
520    9_
$a OBJECTIVE: The aim of our study was to test whether ketamine produces an antidepressant effect in animal model of olfactory bulbectomy and assess the role of mammalian target of rapamycin (mTOR) pathway in ketamine's antidepressant effect. METHODS: Bulbectomized (OBX) rats and sham controls were assigned to four subgroups according to the treatment they received (ketamine, saline, ketamine + rapamycin, and saline + rapamycin). The animals were subjected to open field (OF), elevated plus maze (EPM), passive avoidance (PA), Morris water maze (MWM), and Carousel maze (CM) tests. Blood samples were collected before and after drug administration for analysis of phosphorylated mTOR level. After behavioral testing, brains were removed for evaluation of brain-derived neurotrophic factor (BDNF) in prefrontal cortex (PFC) and hippocampus. RESULTS: Ketamine normalized hyperactivity of OBX animals in EPM and increased the time spent in open arms. Rapamycin pretreatment resulted in elimination of ketamine effect in EPM test. In CM test, ketamine + rapamycin administration led to cognitive impairment not observed in saline-, ketamine-, or saline + rapamycin-treated OBX rats. Prefrontal BDNF content was significantly decreased, and level of mTOR was significantly elevated in OBX groups. CONCLUSIONS: OBX animals significantly differed from sham controls in most of the tests used. Treatment had more profound effect on OBX phenotype than controls. Pretreatment with rapamycin eliminated the anxiolytic and antidepressant effects of ketamine in task-dependent manner. The results indicate that ketamine + rapamycin application resulted in impaired stress responses manifested by cognitive deficits in active place avoidance (CM) test. Intensity of stressor (mild vs. severe) used in the behavioral tests had opposite effect on controls and on OBX animals.
650    _2
$a zvířata $7 D000818
650    _2
$a antidepresiva $x farmakologie $7 D000928
650    _2
$a úzkost $x psychologie $7 D001007
650    _2
$a učení vyhýbat se $x účinky léků $7 D001362
650    _2
$a mozkový neurotrofický faktor $x metabolismus $7 D019208
650    _2
$a hipokampus $x účinky léků $x metabolismus $7 D006624
650    _2
$a ketamin $x antagonisté a inhibitory $x farmakologie $7 D007649
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a bludiště - učení $x účinky léků $7 D018782
650    _2
$a bulbus olfactorius $x fyziologie $7 D009830
650    _2
$a prefrontální mozková kůra $x účinky léků $x metabolismus $7 D017397
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a sirolimus $x farmakologie $7 D020123
650    _2
$a TOR serin-threoninkinasy $x účinky léků $x metabolismus $7 D058570
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kleteckova, Lenka $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic.
700    1_
$a Škurlová, Martina $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic. $7 xx0226211
700    1_
$a Říčný, Jan $u National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic. $7 xx0153151
700    1_
$a Stuchlík, Aleš, $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. $d 1974- $7 xx0014340
700    1_
$a Valeš, Karel $u The Institute of Physiology, Academy of Sciences of the Czech Republic, v.v.i., Videnska 1083, 14220, Prague, Czech Republic. vales@biomed.cas.cz. National Institute of Mental Health, Topolova 748, 250 67 Klecany, Prague East, Czech Republic. vales@biomed.cas.cz. $7 xx0070865
773    0_
$w MED00003990 $t Psychopharmacology $x 1432-2072 $g Roč. 233, č. 11 (2016), s. 2077-2097
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27004790 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20181026093205 $b ABA008
999    __
$a ok $b bmc $g 1200466 $s 974779
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 233 $c 11 $d 2077-2097 $e 20160323 $i 1432-2072 $m Psychopharmacology $n Psychopharmacology $x MED00003990
GRA    __
$a NT13403 $p MZ0
LZP    __
$a Pubmed-20170413

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...